A study to evaluate the effect of Vorapaxar on the pharmacokinetics, safety, tolerability and pharmacodynamic assessment of Rosiglitazone in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 13 Dec 2015
At a glance
- Drugs Vorapaxar (Primary) ; Rosiglitazone
- Indications Arterial thrombosis; Blood coagulation disorders; Inflammation
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 13 Dec 2015 New trial record